Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Semin Hematol. 2011 Oct;48(4):251-8. doi: 10.1053/j.seminhematol.2011.08.002.
Thrombocytopenia is one of the most common reasons for inpatient hematology consultations. The main challenges in the management of hospitalized patients with thrombocytopenia are to identify the underlying cause and to recognize when urgent interventions are required. Examination of the blood film is essential in the investigation of any patient with thrombocytopenia, and the context in which thrombocytopenia occurred, its severity, timing, and association with bleeding are important clues to the diagnosis. Evidence from randomized trials provides some guidance on the use of platelet transfusions for patients with chemotherapy-induced thrombocytopenia; however, recommendations for non-oncology patients are based largely on expert opinion. Thrombocytopenia does not protect against thrombosis and antithrombotic therapy is often required for patients despite very low platelet counts and as a general rule, antithrombotic therapy should not be withheld because of thrombocytopenia alone. In this article normal platelet homeostasis and the epidemiology of thrombocytopenia in hospitalized patients are reviewed. We provide a practical approach to the investigation and management of this common problem and discuss contentious issues including when to use platelet transfusions and how to manage antithrombotic therapy in the setting of thrombocytopenia.
血小板减少症是住院患者血液科会诊最常见的原因之一。治疗住院血小板减少症患者的主要挑战是确定潜在病因,并认识到何时需要紧急干预。对任何血小板减少症患者进行检查时,都必须检查血涂片,血小板减少症发生的背景、严重程度、时间和与出血的关系是诊断的重要线索。随机试验的证据为接受化疗引起的血小板减少症的患者使用血小板输注提供了一些指导;然而,对非肿瘤患者的建议主要基于专家意见。血小板减少症并不能预防血栓形成,尽管血小板计数非常低,仍需要对患者进行抗血栓治疗,一般来说,不应因血小板减少症单独而拒绝抗血栓治疗。本文回顾了正常血小板稳态和住院患者血小板减少症的流行病学。我们提供了一种实用的方法来调查和管理这一常见问题,并讨论了一些有争议的问题,包括何时使用血小板输注以及如何在血小板减少症的情况下管理抗血栓治疗。